BIOMAT Database Logo BIOMAT Database Logo

[The pharmacotherapy of rheumatoid diseases (3): clinical pharmacological points of view]. 1969

B Edström, and F Sjöqvist

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010653 Phenylbutazone A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS. Diphenylbutazone,Fenilbutazon,Butacote,Butadion,Butadione,Butapirazol,Butapyrazole,Butazolidin
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000042 Absorption The physical or physiological processes by which substances, tissue, cells, etc. take up or take in other substances or energy.
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents

Related Publications

B Edström, and F Sjöqvist
[Pharmacotherapy from conception to delivery. Current points of view].
October 1967, Nordisk medicin,
B Edström, and F Sjöqvist
Rheumatoid arthritis in review: Clinical, anatomical, cellular and molecular points of view.
March 2018, Clinical anatomy (New York, N.Y.),
B Edström, and F Sjöqvist
[New points of view of pharmacotherapy of diabetes with sulfonyl ureas].
July 1958, Munchener medizinische Wochenschrift (1950),
B Edström, and F Sjöqvist
[The pharmacotherapy of rheumatoid diseases (6): chloroquine preparations].
October 1969, Lakartidningen,
B Edström, and F Sjöqvist
[The pharmacotherapy of rheumatoid diseases (1): a chemical survey].
October 1969, Lakartidningen,
B Edström, and F Sjöqvist
[Mechanical stress and cellular function: physiological and pharmacological points of view].
September 1997, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
B Edström, and F Sjöqvist
[The pharmacotherapy of rheumatoid diseases (5): salicylates, butazone preparations and indomethacin].
October 1969, Lakartidningen,
B Edström, and F Sjöqvist
[The pharmacotherapy of rheumatoid diseases (4): pathogenesis of inflammation of the joints].
October 1969, Lakartidningen,
B Edström, and F Sjöqvist
[Some clinical points of view on digestive allergy].
January 1953, Acta gastro-enterologica Belgica,
B Edström, and F Sjöqvist
Points of view.
February 1993, Nursing standard (Royal College of Nursing (Great Britain) : 1987),
Copied contents to your clipboard!